- Home
- RVP vs CASI Comparison
RVP vs CASI Comparison
Compare RVP & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- CASI
- Stock Information
- Founded
- RVP 1994
- CASI 1991
- Country
- RVP United States
- CASI China
- Employees
- RVP N/A
- CASI N/A
- Industry
- RVP Medical/Dental Instruments
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- RVP Health Care
- CASI Health Care
- Exchange
- RVP Nasdaq
- CASI Nasdaq
- Market Cap
- RVP 19.8M
- CASI 20.5M
- IPO Year
- RVP 2001
- CASI 1996
- Fundamental
- Price
- RVP $0.66
- CASI $1.41
- Analyst Decision
- RVP
- CASI Strong Buy
- Analyst Count
- RVP 0
- CASI 1
- Target Price
- RVP N/A
- CASI $4.00
- AVG Volume (30 Days)
- RVP 33.3K
- CASI 313.0K
- Earning Date
- RVP 08-13-2025
- CASI 08-15-2025
- Dividend Yield
- RVP N/A
- CASI N/A
- EPS Growth
- RVP N/A
- CASI N/A
- EPS
- RVP N/A
- CASI N/A
- Revenue
- RVP $33,745,343.00
- CASI $31,368,000.00
- Revenue This Year
- RVP N/A
- CASI N/A
- Revenue Next Year
- RVP N/A
- CASI N/A
- P/E Ratio
- RVP N/A
- CASI N/A
- Revenue Growth
- RVP N/A
- CASI 8.39
- 52 Week Low
- RVP $0.56
- CASI $1.09
- 52 Week High
- RVP $1.21
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- RVP 49.53
- CASI 44.64
- Support Level
- RVP $0.63
- CASI $1.23
- Resistance Level
- RVP $0.67
- CASI $1.50
- Average True Range (ATR)
- RVP 0.03
- CASI 0.14
- MACD
- RVP 0.00
- CASI 0.02
- Stochastic Oscillator
- RVP 49.25
- CASI 68.09
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.